13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
|
Name |
WKN |
Börse |
Kurs |
Datum/Zeit |
Diff. |
Diff. % |
Geld |
Brief |
Erster |
Schluss |
|
SANOFI SA INHABER EO 2 |
920657 |
Frankfurt |
89,760 |
27.05.24 17:45:06 |
+0,110 |
+0,12% |
0,000 |
0,000 |
89,340 |
89,760 |
|
REGENERON PHARMAC.DL-,001 |
881535 |
Frankfurt |
904,600 |
27.05.24 09:15:33 |
-6,200 |
-0,68% |
0,000 |
0,000 |
910,800 |
904,600 |